The place for short-acting opioids: Special emphasis on remifentanil

Critical Care

Volumn 12, Issue SUPPL. 3, 2008, Pages

  Wilhelm, Wolfram ^a   Kreuer, Sascha ^b  

^a St Marien Hospital Lunen   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ESTERASE; FENTANYL; MIDAZOLAM; MORPHINE; MORPHINE 6 GLUCURONIDE; OPIATE; PIRITRAMIDE; PROPOFOL; REMIFENTANIL; SHORT ACTING DRUG; SUFENTANIL; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ALGORITHM; ANALGESIA; ARTIFICIAL VENTILATION; BOLUS INJECTION; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG DOSE SEQUENCE; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG MEGADOSE; DRUG METABOLISM; DRUG PENETRATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME SPECIFICITY; HISTAMINE RELEASE; HUMAN; HYPOTENSION; INFUSION RATE; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LIVER METABOLISM; MONOTHERAPY; MUSCLE RIGIDITY; NAUSEA; NEUROSURGERY; PAIN; PRIORITY JOURNAL; PRURITUS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; REVIEW; SEDATION; SHIVERING; SIDE EFFECT; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT; DRUG TOLERANCE; POSTOPERATIVE PAIN;

ANALGESICS, OPIOID; DRUG TOLERANCE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; PAIN, POSTOPERATIVE; PIPERIDINES;

EID: 45949100868     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6821     Document Type: Review

References (34)

1. Novaes MA Knobel E Bork AM Pavao OF Noqueira-Martins LA Ferraz MB Stressors in ICU: Perception of the patient, relatives and healthcare team Intensive Care Med 1999, 25:1421-1426. 10.1007/s001340051091 10660851
2. Soliman HM Melot C Vincent JL Sedative and analgesic practice in the intensive care unit: The results of a European survey Br J Anaesth 2001, 87:186-192. 10.1093/bja/87.2.186 11493487
3. Mazoit JX Butscher K Samii K Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites Anesth Analg 2007, 105:70-78. 10.1213/01.ane.0000265557.73688.32 17578959
4. Jacobi J Fraser GL Coursin DB Riker RR Fontaine D Wittbrodt ET Chalfin DB Masica MF Bjerke HS Coplin WM Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult Crit Care Med 2002, 30:119-141. 10.1097/00003246-200201000-00020 11902253
5. Martin J Bäsell K Bürkle H Hommel J Huth G Kessler P Kretz FJ Putensen Ch Quintel M Tonner P Analgesia and sedation in intensive care medicine. S2-Guidelines of the German Society of Anaesthesiology and Intensive Care Medicine Anästhesiol Intensivmed 2005, 46(Suppl 1):20.
6. Klees TM Sheffels P Dale O Kharasch ED Metabolism of alfentanil by cytochrome P4503A (CYP3A) enzymes Drug Metab Dispos 2005, 33:303-311. 10.1124/dmd.104.002709 15557344
7. Kress JP Pohlman AS O'Connor MF Hal JB Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation N Engl J Med 2000, 342:1471-1477. 10.1056/NEJM200005183422002 10816184
8. Kollef MH Levy NT Ahrens TS Schaiff R Prentice D Sherman G The use of continuous IV sedation is associated with prolongation of mechanical ventilation Chest 1998, 114:541-548. 10.1378/chest.114.2.541 9726743
9. Rathgeber J Schorn B Falk V Kazmaier S Spiegel T Burchardi H The influence of controlled mandatory ventilation (CMV), intermittent mandatory ventilation (IMV) and biphasic intermittent positive airway pressure (BIPAP) on duration of intubation and consumption of analgesics and sedatives. A prospective analysis in 596 patients following adult cardiac surgery Eur J Anaesthesiol 1997, 14:576-582. 10.1046/ j.1365-2346.1994.00178.x 9466092
10. Egan TD Lemmens HJ Fiset P Hermann DJ Muir KT Stanski DR Shafer SL The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers Anesthesiology 1993, 79:881-892. 10.1097/00000542-199311000-00004 7902032
11. Glass PSA Gan TJ Howell S A review of the pharmacokinetics and pharmacodynamics of remifentanil Anesth Analg 1999, 89(Suppl 7):14. 10.1097/00000539-199910001-00003
12. Cox EH Langemeijer MWE Gubbens-Stibbe JM Muir KT Danhof M The comparative pharmacodynamics of remifentanil and its metabolite, GR9 in a rat electroencephalographic model Anesthesiology 0291, 90:535-544. 10.1097/00000542-199902000-00030
13. Scott LJ Perry CM Remifentanil: A review of its use during the induction and maintenance of general anaesthesia Drugs 2005, 65:1793-1823. 10.2165/ 00003495-200565130-00007 16114980
14. Hoke JF Shlugman D Dershwitz M Michalowski P Malthouse-Dufore S Connors PM Martel D Rosow CE Muir KT Rubin N Glass PS Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers Anesthesiology 1997, 87:533-541. 10.1097/ 00000542-199709000-00012 9316957
15. Pitsiu M Wilmer A Bodenham A Breen D Bach V Bonde J Kessler P Albrecht S Fisher G Kirkham A Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment Br J Anaesth 2004, 92:493-503. 10.1093/bja/aeh086 14766712
16. Westmoreland CL Hoke JF Sebel PS Hug CC Muir KT Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery Anesthesiology 1993, 79:893-903. 10.1097/00000542-199311000-00005 7902033
17. Evans TN Park GR Remifentanil in the critically ill Anaesthesia 1997, 52:800-801. 9291773
18. Soltész S Biedler A Silomon M Schöpflin I Molter GP Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery Br J Anaesth 2001, 86:763-768. 10.1093/bja/86.6.763 11573581
19. Wilhelm W Dorscheid E Schlaich N Niederprüm Deller D The use of remifentanil in critically ill patients. Clinical findings and early experience Anaesthesist 1999, 48:625-629. 10.1007/s001010050762 10525595
20. Dahaba AA Grabner T Rehak PH List WF Metzler H Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: A randomized double blind study Anesthesiology 2004, 101:640-646. 10.1097/00000542-200409000-00012 15329588
21. Müllejans B López A Cross MH Bonome C Morrison L Kirkham AJT Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: A randomized, double-blind controlled trial Crit Care 2004, 8:R1-R11. 420059 14975049 10.1186/cc2398
22. Müllejans B Matthey T Scholpp J Schill M Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: A randomised, open-label, pharmacoeconomic trial Critical Care 2006, 10:R91. 1550941 16780597 10.1186/cc4939
23. Baillard C Cohen Y Le Toumelin P Karoubi P Hoang P Ait Kaci F Cupa M Fosse JP Remifentanil-midazolam compared to sufentanil-midazolam for ICU long-term sedation Ann Fr Anesth Reanim 2005, 24:480-486. 15904728
24. Engelhard K Reeker W Kochs E Werner C Effect of remifentanil on intracranial pressure and cerebral blood flow velocity in patients with head trauma Acta Anaesthesiol Scand 2004, 48:396-399. 10.1111/ j.0001-5172.2004.00348.x 15025597
25. Leone M Albanese J Viviand X Garnier F Bourgoin A Barrau K Martin C The effects of remifentanil on endotracheal suctioning-induced increases in intracranial pressure in head-injured patients Anesth Analg 2004, 99:1193-1198. 10.1213/01.ANE.0000132546.79769.91 15385374
26. Karabinis A Mandragos K Stergiopoulos S Komnos A Soukup J Speelberg B Kirkham AJT Safety and efficacy of analgesia-based sedation using remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: A randomised, controlled trial [ISRCTN50308308] Crit Care 2004, 8:R268-R280. 522854 15312228 10.1186/ cc2896
27. Bauer C Kreuer S Ketter R Grundmann U Wilhelm W Remifentanil-propofol versus fentanyl-midazolam combinations for intracranial surgery: Influence of anaesthesia technique and intensive sedation on ventilation times and duration of stay in the ICU Anaesthesist 2007, 56:128-132. 10.1007/s00101-006-1130-4 17235542
28. Dershwitz M Hoke JF Rosow CE Michalowski P Connors PM Muir KT Dienstag JL Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease Anesthesiology 1996, 84:812-820. 10.1097/00000542-199604000-00008 8638835
29. Navapurkar VU Archer S Gupta SK Muir KT Frazer N Park GR Metabolism of remifentanil during liver transplantation Br J Anaesth 1998, 81:881-886. 10211013
30. Breen D Wilmer A Bodenham A Bach V Bonde J Kessler P Albrecht S Shaikh S Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment Crit Care 2004, 8:R21-R30. 420060 14975051 10.1186/cc2399
31. Breen D Karabinis A Malbrain M Morais R Albrecht S Jarnvig IL Parkinson P Kirkham AJT Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: A randomised trial [ISRCTN47583497] Crit Care 2005, 9:R200-R210. 1175879 15987391 10.1186/cc3495
32. Park G Lane M Rogers S Bassett P A comparison of hypnotic and analgesic based sedation in a general intensive care unit Br J Anaesth 2007, 98:76-82. 10.1093/bja/ael320 17158127
33. Wilhelm W Wrobel M Kreuer S Larsen R Remifentanil: An update Anaesthetist 2003, 52:473-494.
34. Bouillon T Kietzmann D Port R Meineke I Hoeft A Population pharmacokinetics of piritramide in surgical patients Anesthesiology 1999, 90:7-15. 10.1097/00000542-199901000-00004 9915307